Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
In the latest session, PACS Group Inc (NYSE: PACS) closed at $32.16 up 1.20% from its previous closing price of $31.78. In other words, the price has increased by $1.20 from its previous closing price. On the day, 1.28 million shares were traded. PACS stock price reached its highest trading level at $32.6 during the session, while it also had its lowest trading level at $31.17.
Ratios:
For a deeper understanding of PACS Group Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 14.03 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 12.81. For the most recent quarter (mrq), Quick Ratio is recorded 0.94 and its Current Ratio is at 0.94. In the meantime, Its Debt-to-Equity ratio is 4.19 whereas as Long-Term Debt/Eq ratio is at 3.83.
On October 09, 2024, UBS started tracking the stock assigning a Buy rating and target price of $50.UBS initiated its Buy rating on October 09, 2024, with a $50 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 24 ’25 when Dilsaver Evelyn S bought 16,724 shares for $29.90 per share. The transaction valued at 499,997 led to the insider holds 22,739 shares of the business.
MITCHELL JOHN TODD sold 159,556 shares of PACS for $4,768,379 on Nov 24 ’25. The Chief Legal Officer & Sec. now owns 755,836 shares after completing the transaction at $29.89 per share. On Nov 24 ’25, another insider, John Todd Mitchell, who serves as the Chief Legal Officer of the company, bought 159,556 shares for $27.50 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PACS now has a Market Capitalization of 4990508544 and an Enterprise Value of 8340666880. As of this moment, PACS’s Price-to-Earnings (P/E) ratio for their current fiscal year is 31.01, and their Forward P/E ratio for the next fiscal year is 15.27. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.57. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.98 while its Price-to-Book (P/B) ratio in mrq is 5.78. Its current Enterprise Value per Revenue stands at 1.623 whereas that against EBITDA is 24.525.
Stock Price History:
The Beta on a monthly basis for PACS is -1.61, which has changed by 1.0341556 over the last 52 weeks, in comparison to a change of 0.12934029 over the same period for the S&P500. Over the past 52 weeks, PACS has reached a high of $32.19, while it has fallen to a 52-week low of $7.50. The 50-Day Moving Average of the stock is 121.30%, while the 200-Day Moving Average is calculated to be 166.03%.
Shares Statistics:
For the past three months, PACS has traded an average of 1.58M shares per day and 4725790 over the past ten days. A total of 156.62M shares are outstanding, with a floating share count of 39.48M. Insiders hold about 74.79% of the company’s shares, while institutions hold 28.21% stake in the company. Shares short for PACS as of 1763078400 were 3357277 with a Short Ratio of 2.13, compared to 1760486400 on 3313495. Therefore, it implies a Short% of Shares Outstanding of 3357277 and a Short% of Float of 7.249999999999999.
